Correspondence: Professor X-J Huang, Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Peking-Tsinghua Center for Life Sciences, 11 Xizhimen South Street, Beijing 100044, China. E-mail: huangxiaojun@bjmu.edu.cn of high-risk adult ALL patients in their first complete remission are able to receive an HLA-matched sibling stem cell transplant.
http://ift.tt/1DxPfaz
http://ift.tt/1DxPfaz
No comments:
Post a Comment